486 reports of this reaction
2.2% of all PHYTONADIONE reports
#5 most reported adverse reaction
DYSPNOEA is the #5 most commonly reported adverse reaction for PHYTONADIONE, manufactured by Hospira, Inc.. There are 486 FDA adverse event reports linking PHYTONADIONE to DYSPNOEA. This represents approximately 2.2% of all 21,707 adverse event reports for this drug.
Patients taking PHYTONADIONE who experience dyspnoea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DYSPNOEA is a less commonly reported adverse event for PHYTONADIONE, but still significant enough to appear in the safety profile.
In addition to dyspnoea, the following adverse reactions have been reported for PHYTONADIONE:
The following drugs have also been linked to dyspnoea in FDA adverse event reports:
DYSPNOEA has been reported as an adverse event in 486 FDA reports for PHYTONADIONE. This does not prove causation, but indicates an association observed in post-market surveillance data.
DYSPNOEA accounts for approximately 2.2% of all adverse event reports for PHYTONADIONE, making it a notable side effect.
If you experience dyspnoea while taking PHYTONADIONE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.